This may well turn out to be a dog and there’s no doubt that strategy from management has been incredibly poor and communication.... well, non-existent! The company has been run poorly but I can’t help but think that a product that improves UI to a point where surgery may not be required, should be every clinician’s first option prior to recommending surgery. Couple that with the knowledge that a strong pelvic floor improves POP cases and sexual pleasure and this product has everything a multinational should want. I mean if the essential oil market is worth $10 Billion, there’s definitely a market for Pericoach! I’m holding on for the ride.
- Forums
- ASX - By Stock
- Ann: PeriCoach CE Marking for Treatment of Pelvic Organ Prolapse
This may well turn out to be a dog and there’s no doubt that...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online